A Trial of "Armored" CAR T Cells Targeting CD19 For Patients With Relapsed CD19+ Hematologic Malignancies

Name: A Trial of "Armored" CAR T Cells Targeting CD19 For Patients With Relapsed CD19+ Hematologic Malignancies
Published: 2017
License: Public Domain

Memorial Sloan Kettering Cancer Center · 2017

ClinicalTrials.gov · Datasets · License: Public Domain · 2017

Open Source ↗

chronic lymphocytic leukemia (cll), relapsed, refractory, car t cells targeting cd19, egfrt/19-28z/4-1bbl, 16-1570, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Trial of "Armored" CAR T Cells Targeting CD19 For Patients With Relapsed CD19+ Hematologic Malignancies

Related documents